Evidence map›Paper›PMID 35975159›Full record

ArticleChemical science2022

Iridium-catalyzed α-selective deuteration of alcohols.

Moeko Itoga, Masako Yamanishi, Taro Udagawa, Ayane Kobayashi, Keiko Maekawa, Yoshiji Takemoto, Hiroshi Naka

Abstract read
In one paragraph

Article in Chemical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Water-Dispersible Ruthenium Nanocatalyst for Carbonyl Reduction With DAngewandte Chemie (International ed. in English) · 2026
    Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Moeko ItogaGraduate School of Pharmaceutical Sciences, Kyoto University Kyoto 606-8501 Japan h_naka@pharm.kyoto-u.ac.jp.ORCID https://orcid.org/0000-0003-0017-7861
Masako YamanishiGraduate School of Pharmaceutical Sciences, Kyoto University Kyoto 606-8501 Japan h_naka@pharm.kyoto-u.ac.jp.
Taro UdagawaDepartment of Chemistry and Biomolecular Science, Faculty of Engineering, Gifu University Yanagido 1-1 Gifu 501-1193 Japan.ORCID https://orcid.org/0000-0002-4072-253X
Ayane KobayashiFaculty of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts Kodo, Kyotanabe Kyoto 610-0395 Japan.
Keiko MaekawaFaculty of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts Kodo, Kyotanabe Kyoto 610-0395 Japan.ORCID https://orcid.org/0000-0003-4857-4137
Yoshiji TakemotoGraduate School of Pharmaceutical Sciences, Kyoto University Kyoto 606-8501 Japan h_naka@pharm.kyoto-u.ac.jp.ORCID https://orcid.org/0000-0003-1375-3821
Hiroshi NakaGraduate School of Pharmaceutical Sciences, Kyoto University Kyoto 606-8501 Japan h_naka@pharm.kyoto-u.ac.jp.ORCID https://orcid.org/0000-0002-1198-6835

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of chemoselective C(sp

Identifiers

PMID35975159
PMCPMC9350590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.